Common Cold

NEW ORLEANS — At the ACP Internal Medicine Meeting, Douglas S. Paauw, MD, MACP, a professor of medicine at the University of Washington, addressed several common medical myths among patients.

The FDA has proposed an order for the removal of oral phenylephrine as an active ingredient from over-the-counter monograph drug products for relieving nasal congestion, according to an administration press release.

A Korean study identified a 22% increased risk for seizure among young children who were prescribed first-generation antihistamines, according to findings published in JAMA Network Open.

Sinusitis, acute respiratory tract burden and even pharyngitis — also known as the common cold — are potential risk factors for rheumatoid arthritis, according to data published in The Journal of Rheumatology.

Consuming more of vitamins A, E and D may help lower respiratory complaints, according to research published in BMJ Nutrition, Prevention & Health.

In a recent survey of more than 2,000 U.S. adults, 86% reported not knowing the symptoms of pulmonary fibrosis, according to a press release from the Pulmonary Fibrosis Foundation.

A novel therapeutic treatment using a common cold virus could be effective in patients with nonmuscle-invasive bladder cancer, and breast cancer history was associated with an increased risk for congestive heart failure later in life.

The FDA has issued a safety alert that an Ayurvedic medicine — intended to treat rickets, cough and cold, worm infections and teething among infants — has been linked to two cases of lead poisoning.

Hypertonic saline nose drops shortened cold symptom duration in young children and decreased household transmission, according to findings presented at the European Respiratory Society International Congress in Vienna.